The 52-Week Low Club (PALM) (MOT)
Palm (PALM) Already weak company in the same sector as iPhone, Dragged down by bad news from Apple (AAPL). Falls to $4.25 from 52-week high of $19.50. Human Genome Sciences (HGSI) Clinical trials set-back. Falls to $5.22 from 52-week high…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Palm (PALM) Already weak company in the same sector as iPhone, Dragged down by bad news from Apple (AAPL). Falls to $4.25 from 52-week high of $19.50.
Human Genome Sciences (HGSI) Clinical trials set-back. Falls to $5.22 from 52-week high of $12.12.
Ciena (CIEN) Market does not like latest acquisition. Trades off to $21.40 from 52-week high of $49.55.
Motorola (MOT) Just when no one thought it could get worse. Shares drop to $9.43 from 52-week high of $19.98.
Qimonda Ag (QI) Weak results and downgrades for semiconductor company. Falls off to $3.51 from 52-week high of $17.29.
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.